Stock DNA
Pharmaceuticals & Biotechnology
ILS 78 Million ()
NA (Loss Making)
NA
0.00%
-0.32
54.40%
-11.05
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2016)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
96.92%
0%
96.92%
6 Months
91.55%
0%
91.55%
1 Year
53.46%
0%
53.46%
2 Years
-45.69%
0%
-45.69%
3 Years
452.37%
0%
452.37%
4 Years
-75.94%
0%
-75.94%
5 Years
-95.02%
0%
-95.02%
Silver Castle Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.36%
EBIT Growth (5y)
9.28%
EBIT to Interest (avg)
-4.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
-0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-11.68
EV to EBIT
-22.18
EV to EBITDA
-23.72
EV to Capital Employed
-17.54
EV to Sales
85.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
Bearish
Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.60
-0.90
33.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.70
-0.90
22.22%
Operating Profit Margin (Excl OI)
-18,147.10%
-36,423.10%
1,827.60%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is 0.00% vs 0.00% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 22.22% vs -12.50% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1.40
5.10
-72.55%
Operating Profit (PBDIT) excl Other Income
-9.10
-7.80
-16.67%
Interest
0.40
0.70
-42.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-10.10
-8.80
-14.77%
Operating Profit Margin (Excl OI)
-6,509.70%
-1,620.40%
-488.93%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -72.55% vs 75.86% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -14.77% vs -41.94% in Dec 2024






